Patents by Inventor James C. Oliver

James C. Oliver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Continuous Delivery of Lenalidomide and Other Immunomodulatory Agents
    Publication number: 20220054473
    Abstract: Provided are systems and methods for continuously administering to a subject in need of treatment a formulation comprising an immunomodulatory imide compound. In some embodiments, the method are for use in treating multiple myeloma, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes, mantle cell lymphoma, hematologic cancers, or solid tumor cancers.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Marina Borovinskaya, Fotios Plakogiannis, Nisarg Modi, Tamanna Lather, Rod L. Hartwig, James C. Oliver
  • Continuous delivery of lenalidomide and other immunomodulatory agents
    Patent number: 11197852
    Abstract: Provided are methods for continuously administering to a subject in need of treatment a formulation comprising an immunomodulatory imide compound. In some embodiments, the method are for use in treating multiple myeloma, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes, mantle cell lymphoma, hematologic cancers, or solid tumor cancers.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: December 14, 2021
    Assignee: Starton Therapeutics, Inc.
    Inventors: Marina Borovinskaya, Fotios Plakogiannis, Nisarg Modi, Tamanna Lather, Rod L. Hartwig, James C. Oliver, Yuliya Levintova
  • CONTINUOUS DELIVERY OF LENALIDOMIDE AND OTHER IMMUNOMODULATORY AGENTS
    Publication number: 20200330445
    Abstract: Provided are methods for continuously administering to a subject in need of treatment a formulation comprising an immunomodulatory imide compound. In some embodiments, the method are for use in treating multiple myeloma, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes, mantle cell lymphoma, hematologic cancers, or solid tumor cancers.
    Type: Application
    Filed: April 21, 2020
    Publication date: October 22, 2020
    Inventors: Marina BOROVINSKAYA, Fotios PLAKOGIANNIS, Nisarg MODI, Tamanna LATHER, Rod L. Hartwig, James C. OLIVER
  • METHODS FOR REPAIR OF EAR CANAL TISSUE DEFECTS
    Publication number: 20150104494
    Abstract: Disclosed herein are methods of repairing ear canal tissue defects by administering non-basic fibroblast growth factor (FGF) to the ear canal tissue defect. Also disclosed are delivery devices to administer said non-basic FGF.
    Type: Application
    Filed: October 14, 2014
    Publication date: April 16, 2015
    Inventors: James C. Oliver, Judi Appleman, Wei Chen, D. Bradley Welling
  • TREATMENT OF CANCER
    Publication number: 20110245201
    Abstract: Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.
    Type: Application
    Filed: March 14, 2011
    Publication date: October 6, 2011
    Inventors: John Ryan, Thomas Schluep, Yun Yen, James C. Oliver, Mark Davis
  • Detonating cord cutter
    Patent number: 6049985
    Abstract: A cutter for cutting a detonating cord comprises a first jaw and a second jaw that are pivotable relative to each other. An anvil is mounted on the second jaw and has a first opening for receiving a cord and a second opening intersecting with the first opening. A blade is mounted on the second jaw and has a cutting edge that is arranged to slide into the second opening when the first and second jaws are pivoted toward each other.
    Type: Grant
    Filed: August 5, 1998
    Date of Patent: April 18, 2000
    Assignee: Schlumberger Technology Corporation
    Inventors: Manuel T. Gonzalez, James C. Oliver, Andrew T. Werner, Klaus B. Huber
  • Method and apparatus for storing bicarbonate dialysate
    Patent number: 4584176
    Abstract: The stability of bicarbonate dialysate is maintained over a prolonged period by maintaining a blanket of CO.sub.2 at atmospheric pressure over the solution in an air-tight storage tank having a non-leaching interior. The CO.sub.2 blanket is kept at atmospheric pressure in the storage tank by use of a negative pressure regulator connected to the CO.sub.2 gas cylinder. HCO.sub.3 in the stored dialysate remained stable for as long as thirty days.
    Type: Grant
    Filed: March 19, 1984
    Date of Patent: April 22, 1986
    Inventors: James C. Oliver, Carl W. Oettinger